MSC-NP

autologous mesenchymal stem cell-derived neural progenitors · Tisch MS Research Center of New York

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSC-NP, covering 2025-08-17 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

See pricing